Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases

  • ACS Med Chem Lett. 2022 Mar 2;13(4):524-525. doi: 10.1021/acsmedchemlett.2c00059.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia30309, United States.
PMID: 35450352 DOI: 10.1021/acsmedchemlett.2c00059
Products